Every SEC Form 3/4/5 on record for this filer (CIK 1264519) — 8 issuers, 75 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC | Director | 2016-06-24 → 2026-06-22 | 69 | −$8M |
| VTVT | vTv Therapeutics Inc. | Pres, CEO and Exec Chairperson · Director | 2022-08-08 → 2026-02-18 | 5 | $83,817 |
| LBPH | Longboard Pharmaceuticals, Inc. | Director | 2021-03-11 → 2024-12-02 | 5 | — |
| AXLA | Axcella Health Inc. | Director · lapsed | 2022-05-25 → 2022-05-25 | 2 | — |
| PHGE | BiomX Inc. | Director · lapsed | 2020-10-05 → 2021-07-30 | 4 | $50,000 |
| ALPN | ALPINE IMMUNE SCIENCES, INC. | Director · lapsed | 2018-01-04 → 2020-01-06 | 3 | — |
| ENUM | Enumeral Biomedical Holdings, Inc. | Director · lapsed | 2015-09-24 → 2016-12-13 | 2 | — |
| NVLS | Nivalis Therapeutics, Inc. | Director · lapsed | 2016-03-02 → 2016-09-14 | 2 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| VTVT | 2024-11-18 | Buy | 1,844 | $16.96 | $31,274 | 5,000 |
| VTVT | 2024-11-15 | Buy | 1,378 | $16.35 | $22,530 | 1,378 |
3 of 8 issuers are covered and open a security page; the rest are on file here only.
